Patent Law Weblog
recent posts
- Moderna Settles Patent Litigation with Arbutus et al.
- USPTO and DOJ Statement of Interest in Collision Communications: Another Thumb on the Scale in Favor of NPE Patent Plaintiffs
- Oasis Tooling, Inc. v. Siemens Industry Software Inc. (Fed. Cir. 2026)
- Why AI Will Not Take Over the World
- BioNTech Sues Moderna over mRNA Vaccine Technology
about
Category: Biotech/Pharma Business
-
By Donald Zuhn — Reflecting upon the events of the past twelve months, Patent Docs presents its fourth annual list of top biotech/pharma patent stories. For 2010, we identified a dozen stories that we covered on Patent Docs last year that we believe had (or are likely to have) the greatest impact on biotech/pharma patent…
-
By Donald Zuhn — Reflecting upon the events of the past twelve months, Patent Docs presents its fourth annual list of top biotech/pharma patent stories. For 2010, we identified a dozen stories that were covered on Patent Docs last year that we believe had (or are likely to have) the greatest impact on biotech/pharma patent…
-
By Donald Zuhn — On Friday, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for the third quarter of 2010. The NVCA quarterly study, which the group conducts with PriceWaterhouseCoopers using data from Thomson Reuters, indicates that venture…
-
By Donald Zuhn — At last week's BIO Investor Forum, the Biotechnology Industry Organization (BIO) announced that the number of publicly traded biotech companies dropped from 394 in the fourth quarter of 2007 to only 294 by the second quarter of 2010. The net loss of 100 biotech companies (or 25% of the sector's publicly…
-
By Donald Zuhn — On Monday, the Association of University Technology Managers (AUTM) announced the results of a survey showing that university start-ups and licensing activity remaining strong even at the height of the country's worst economic crisis since the Great Depression. The AUTM survey found that 596 university start-ups were created in 2009, a…
-
By Donald Zuhn — Last week, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for the second quarter of 2010. The NVCA quarterly study, which the NVCA conducts with PriceWaterhouseCoopers using data from Thomson Reuters, indicates that…
-
By James DeGiulio — Despite the global economic outlook improving considerably over the last year, an industry survey by international intellectual property group Marks & Clerk suggests that the biotech and pharmaceutical industry may be entering a critical phase in terms of drug innovation and development. The research identifies a number of industry-specific problems,…
-
By Kevin E. Noonan — Steve Burrill, President and CEO of Burrill & Co. took the stage at BIO 2010 in Chicago last week, and once again provided in 90 minutes his impressions and opinions on the state of the biotechnology industry. Although decidedly more upbeat than last year, Mr. Burrill's talk, entitled "Adapting…
-
By Donald Zuhn — On Wednesday, while the biotech industry gathered in Chicago for the 2010 BIO International Convention, Deloitte Touche Tohmatsu (DTT) released a white paper suggesting that the global recession has likely permanently reshaped the life sciences industry. To assess the long- and short-term effects of the recession, and determine whether the…
-
By Donald Zuhn — On Wednesday, less than a week before the industry congregates in Chicago for the 2010 BIO International Convention, Ernst & Young issued its 24th annual report on the biotech sector. In the report, entitled "Beyond Borders: Global Biotechnology Report 2010," the professional services firm concludes that "[t]he global biotechnology industry…
Patent Docs 